News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Sanofi (France) (SASY.PA) Accelerates Development of New Lantus Formulation


11/4/2011 7:57:59 AM

Sanofi is accelerating the development of a new Lantus formulation, a move designed to help the drugmaker remain competitive as Novo Nordisk A/S introduces a rival to its best-selling diabetes medicine. Sanofi, France’s biggest drugmaker, said today it will bypass mid-phase clinical trials for the experimental drug, and begin final-stage testing of the product in the first quarter next year. The Paris-based company decided to move directly to late-stage development after consulting with regulatory agencies, Chief Executive Officer Chris Viehbacher told analysts during a conference call.

Read at Bloomberg


comments powered by Disqus
Bloomberg
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES